In recent years, our understanding of the genetic alterations underlying thyroid oncogenesis has greatly expanded. The use of molecular markers, including RAS, in the management of thyroid carcinoma is also increasing. This review summarizes the current literature surrounding RAS and discusses its potential as a diagnostic and prognostic indicator in the management of thyroid cancer.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755930 | PMC |
http://dx.doi.org/10.1634/theoncologist.2013-0072 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!